
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chromophobe renal cell carcinoma: current and controversial issues
Holger Moch, Riuko Ohashi
Pathology (2020) Vol. 53, Iss. 1, pp. 101-108
Open Access | Times Cited: 44
Holger Moch, Riuko Ohashi
Pathology (2020) Vol. 53, Iss. 1, pp. 101-108
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
João Lobo, Riuko Ohashi, Mahul B. Amin, et al.
Histopathology (2022) Vol. 81, Iss. 4, pp. 426-438
Closed Access | Times Cited: 70
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors
Anna Caliò, Matteo Brunelli, Stefano Gobbo, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2441-2441
Open Access | Times Cited: 32
Anna Caliò, Matteo Brunelli, Stefano Gobbo, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2441-2441
Open Access | Times Cited: 32
Comparative Analysis for the Distinction of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma in Computed Tomography Imaging Using Machine Learning Radiomics Analysis
Abeer J. Alhussaini, J. Douglas Steele, Ghulam Nabi
Cancers (2022) Vol. 14, Iss. 15, pp. 3609-3609
Open Access | Times Cited: 22
Abeer J. Alhussaini, J. Douglas Steele, Ghulam Nabi
Cancers (2022) Vol. 14, Iss. 15, pp. 3609-3609
Open Access | Times Cited: 22
TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background
Kristýna Pivovarčíková, Reza Alaghehbandan, Tomáš Vaněček, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 322-322
Open Access | Times Cited: 19
Kristýna Pivovarčíková, Reza Alaghehbandan, Tomáš Vaněček, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 322-322
Open Access | Times Cited: 19
Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer
Francesco Trevisani, Matteo Floris, Roberto Minnei, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2603-2603
Open Access | Times Cited: 19
Francesco Trevisani, Matteo Floris, Roberto Minnei, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2603-2603
Open Access | Times Cited: 19
Liver metastasis from a chromophobe renal cell carcinoma 18 years after initial diagnosis: a case report
Alexandra Ökrösi, Lothar Ponhold, Simon Turba, et al.
Journal of Medical Case Reports (2025) Vol. 19, Iss. 1
Open Access
Alexandra Ökrösi, Lothar Ponhold, Simon Turba, et al.
Journal of Medical Case Reports (2025) Vol. 19, Iss. 1
Open Access
Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation: A Case Report and Review of the Literature
Mouhsine Omari, Mohammed Bendimya, Fadoua Jebrouni, et al.
Cureus (2025)
Open Access
Mouhsine Omari, Mohammed Bendimya, Fadoua Jebrouni, et al.
Cureus (2025)
Open Access
Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma
Andrea Katharina Lindner, Gennadi Tulchiner, Andreas Seeber, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
Andrea Katharina Lindner, Gennadi Tulchiner, Andreas Seeber, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
A transfer learning framework to elucidate the clinical relevance of altered proximal tubule cell states in kidney disease
David Legouis, Anna Maria Rinaldi, Daniele Malpetti, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109271-109271
Open Access | Times Cited: 3
David Legouis, Anna Maria Rinaldi, Daniele Malpetti, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109271-109271
Open Access | Times Cited: 3
Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer
Shengtao Dong, Hua Yang, Zhi‐Ri Tang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Shengtao Dong, Hua Yang, Zhi‐Ri Tang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report
Huimin Zhang, Xiaofeng Cong, Chen Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Huimin Zhang, Xiaofeng Cong, Chen Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset
Ezra Baraban, Roy Elias, Ming-Tseh Lin, et al.
Modern Pathology (2024) Vol. 37, Iss. 5, pp. 100472-100472
Closed Access | Times Cited: 2
Ezra Baraban, Roy Elias, Ming-Tseh Lin, et al.
Modern Pathology (2024) Vol. 37, Iss. 5, pp. 100472-100472
Closed Access | Times Cited: 2
Contemporary Drug Therapy for Renal Cell Carcinoma—Evidence Accumulation and Histological Implications in Treatment Strategy
Kazutoshi Yamana, Riuko Ohashi, Yoshihiko Tomita
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2840-2840
Open Access | Times Cited: 8
Kazutoshi Yamana, Riuko Ohashi, Yoshihiko Tomita
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2840-2840
Open Access | Times Cited: 8
Chromophobe Renal Cell Carcinoma With Extensive Retraction Artifact: A Potential Diagnostic Pitfall From Micropapillary Urothelial Carcinoma
Ankur R. Sangoi, Kristýna Pivovarčíková, Mahmut Akgul, et al.
International Journal of Surgical Pathology (2024)
Closed Access | Times Cited: 1
Ankur R. Sangoi, Kristýna Pivovarčíková, Mahmut Akgul, et al.
International Journal of Surgical Pathology (2024)
Closed Access | Times Cited: 1
A case-report of chromophobe renal cell carcinoma with renal subcapsular hematoma
Yuehui Yin, Shanfang Tang
International Journal of Surgery Case Reports (2024) Vol. 118, pp. 109608-109608
Open Access | Times Cited: 1
Yuehui Yin, Shanfang Tang
International Journal of Surgery Case Reports (2024) Vol. 118, pp. 109608-109608
Open Access | Times Cited: 1
Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study
Jinkui Wang, Chenghao Zhanghuang, Xiaojun Tan, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 6
Jinkui Wang, Chenghao Zhanghuang, Xiaojun Tan, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 6
Characterization of Intercalated Cell Markers KIT and LINC01187 in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms
Rahul Mannan, Xiaoming Wang, Pushpinder Bawa, et al.
International Journal of Surgical Pathology (2022) Vol. 31, Iss. 6, pp. 1027-1040
Closed Access | Times Cited: 6
Rahul Mannan, Xiaoming Wang, Pushpinder Bawa, et al.
International Journal of Surgical Pathology (2022) Vol. 31, Iss. 6, pp. 1027-1040
Closed Access | Times Cited: 6
Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings
Alcino Gama, Hao‐Liang Xu, Ximing J. Yang, et al.
International Journal of Surgical Pathology (2023) Vol. 32, Iss. 1, pp. 11-16
Closed Access | Times Cited: 3
Alcino Gama, Hao‐Liang Xu, Ximing J. Yang, et al.
International Journal of Surgical Pathology (2023) Vol. 32, Iss. 1, pp. 11-16
Closed Access | Times Cited: 3
NFE2L3 as a Potential Functional Gene Regulating Immune Microenvironment in Human Kidney Cancer
Qian Zhang, Donge Tang, Aiyun Zha, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 5
Qian Zhang, Donge Tang, Aiyun Zha, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 5
Are There Ultrasound Features to Distinguish Small (<3 cm) Peripheral Renal Angiomyolipomas From Renal Cell Carcinomas?
Anthony F. Chen, John P. McGahan, Machelle Wilson, et al.
Journal of Ultrasound in Medicine (2023) Vol. 42, Iss. 9, pp. 2083-2094
Closed Access | Times Cited: 2
Anthony F. Chen, John P. McGahan, Machelle Wilson, et al.
Journal of Ultrasound in Medicine (2023) Vol. 42, Iss. 9, pp. 2083-2094
Closed Access | Times Cited: 2
Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation
Benjamin Lichtbroun, Brian Shinder, Tina Gowda Sara, et al.
Journal of Kidney Cancer and VHL (2023) Vol. 10, Iss. 3, pp. 1-8
Open Access | Times Cited: 2
Benjamin Lichtbroun, Brian Shinder, Tina Gowda Sara, et al.
Journal of Kidney Cancer and VHL (2023) Vol. 10, Iss. 3, pp. 1-8
Open Access | Times Cited: 2
Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma
Shuai Liu, Yu Yao, Mingyu Hou, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Shuai Liu, Yu Yao, Mingyu Hou, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics
Khaled Bin Satter, Zach Ramsey, Paul Tran, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3242-3242
Open Access | Times Cited: 4
Khaled Bin Satter, Zach Ramsey, Paul Tran, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3242-3242
Open Access | Times Cited: 4
Renal oncocytoma with adverse pathologic features: a clinical and pathologic study of 50 cases
Khaleel I. Al‐Obaidy, Liang Cheng
Modern Pathology (2021) Vol. 34, Iss. 10, pp. 1947-1954
Open Access | Times Cited: 5
Khaleel I. Al‐Obaidy, Liang Cheng
Modern Pathology (2021) Vol. 34, Iss. 10, pp. 1947-1954
Open Access | Times Cited: 5
External validation of a four-tiered grading system for chromophobe renal cell carcinoma
Shuai Liu, Mingyu Hou, Yu Yao, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
Shuai Liu, Mingyu Hou, Yu Yao, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access